Flora Growth Corp. (FLGC), the Canada based global cannabis focused consumer-packaged goods company and pharmaceutical distributor, has agreed to acquire TruHC Pharma GmbH, the Germany based cannabis company, that holds a GDP wholesale and an EU-GMP processing and production license for medical cannabis, in an all-stock deal in exchange for 2,770,562 Flora common shares, valued at USD 6.4m based on the closing price of the Flora Growth shares on March 28, 2024 of USD 2.31 per share.
- Target – Truhc Pharma GmbH
- Buyer – Flora Growth corp.
- Seller – Shareholders